Back

Sex-related differences in contemporary HFrEF management: insights from the Italian OpTIMa-HF Registry

29 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: balancing titration and renal function Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Federica Marzano

University of Naples Federico II, Naples (Italy)

7 More presentations in this session

Presentation thumbnail
How do we treat patients with chronic kidney disease stages 4-5 and heart failure with reduced left ventricular ejection fraction? Impact on 1-year mortality and hospital admissions
Doctor M. Anguita Gamez (Madrid, ES)
Abstract Slides
Presentation thumbnail
Association between up-titration of guideline-directed medical therapy and clinical outcomes in patients with chronic heart failure with reduced ejection fraction
Doctor Y. Agata (Sapporo, JP)
Abstract Slides
Presentation thumbnail
Sector-level disparities in ESC-recommended GDMT implementation for patients with HFrEF: a real-world retrospective comparative study
Miss R. Niraula (Kobuleti, GE)
Abstract Slides
Presentation thumbnail
Beta-blocker dose titration, functional capacity, and all-cause mortality in patients with heart failure and reduced ejection fraction
Doctor K. Berge (Nordbyhagen, NO)
Abstract Slides
Presentation thumbnail
The effect of left bundle branch block on pharmacotherapy and changes of left ventricular ejection fraction after the rapid-up titration of guideline-directed medical therapy in heart failure
Doctor P. Schaffer (Budapest, HU)
Abstract Slides

Access the full session

Session thumbnail
Heart failure: balancing titration and renal function

The Event

Event poster

ESC Congress 2026

29 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Gender differences in the treatment of heart failure with reduced ejection fraction
29 June 2021
thumbnail
Congress Presentation
Elegibility for Sacubitril/Valsartan in italian clinical practice: insights from the OPTIMA-HF registry
31 August 2024
thumbnail
Congress Presentation
Impact of sex on the burden of sustained ventricular tachyarrhythmic events following LVAD implant: preliminary data from the PIVATAL Trial
14 April 2026
thumbnail
Congress Presentation
Sex disaggregated analysis of risk factors for adverse outcomes in hypertrophic cardiomyopathy
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources